|
Market Closed -
Nasdaq
16:00:00 2024-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 21.55 USD | +0.14% |
|
-.--% | - |
| 24-06-04 | Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete | MT |
| 24-06-03 | Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index | CI |
Company Valuation: FUSN PHAR
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Market Cap 1 | 490.3 | 179.6 | 141 | 695.8 |
| Change | - | -63.37% | -21.49% | 393.48% |
| Enterprise Value (EV) 1 | 267.9 | -14.49 | 10.38 | 512.5 |
| Change | - | -105.41% | 171.66% | 4,837.35% |
| P/E | -3.25x | -2.19x | -1.57x | -6.64x |
| PBR | 1.66x | 0.78x | 0.87x | 3.44x |
| PEG | 0.1x | 0x | -0.3x | 0.2x |
| Capitalization / Revenue | - | 124,712,592x | 96,510,554x | 336,470,078x |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | -7.15x | 0.18x | -0.12x | -5.24x |
| EV / EBIT | -7.06x | 0.18x | -0.12x | -5.17x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -3.618 | -1.903 | -2.003 | -1.446 |
| Distribution rate | - | - | - | - |
| Net sales | - | 1.44 | 1.461 | 2.068 |
| EBITDA 1 | -37.45 | -81.38 | -87.12 | -97.89 |
| EBIT 1 | -37.94 | -82.02 | -88.03 | -99.23 |
| Net income 1 | -78.33 | -81.05 | -87.61 | -94.9 |
| Net Debt 1 | -222.4 | -194.1 | -130.6 | -183.3 |
| Reference price 2 | 11.75 | 4.17 | 3.15 | 9.61 |
| Nbr of stocks (in thousands) | 41,726 | 43,066 | 44,763 | 72,406 |
| Announcement Date | 3/25/21 | 3/17/22 | 3/16/23 | 3/20/24 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FUSN Stock
- Valuation FUSN PHAR
Select your edition
All financial news and data tailored to specific country editions
